PRV-KORO: PRV-based Detection of CAD in Comparison to Standard Methods

Sponsor
University Medicine Greifswald (Other)
Overall Status
Completed
CT.gov ID
NCT02404948
Collaborator
(none)
156
1
26
6

Study Details

Study Description

Brief Summary

This is a validation study comparing a pulse wave based algorithm for the detection of coronary artery disease with parameters from coronary angiography, echocardiography and cardiogoniometry.

Condition or Disease Intervention/Treatment Phase
  • Other: Diagnostic algorithm

Detailed Description

The study will validate a pulse wave based algorithm for the detection of coronary artery disease (CAD) with parameters from standard methods. Subjects will be patients admitted to coronary angiography due to suspected CAD. Pulse wave signals will be analyzed according to novelly established algorithm regarding the presence of CAD and/or myocardial ischemia. These results be compared to the diagnoses made by coronary angiography (primary endpoint): presence of minimum one coronary artery stenose >=50%. For secondary analyses, results will be compared to parameters form echocardiography and cardiogoniometry.

Study Design

Study Type:
Observational
Actual Enrollment :
156 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Comparison of a Pulse Wave Based Approach for Detection of Coronary Artery Disease Compared to Standard Methods
Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Jul 1, 2016
Actual Study Completion Date :
Jun 1, 2017

Outcome Measures

Primary Outcome Measures

  1. Presence of CAD - angio (minimum 1 stenosis >=50%) [1 day]

    Presence of CAD in coronary angiography: minimum 1 stenosis >=50%

Secondary Outcome Measures

  1. Presence of CAD number - angio (Number of coronary vessels with at least 1 stenosis >=50% in coronary angiography) [1 day]

    Number of coronary vessels with at least 1 stenosis >=50% in coronary angiography

  2. Wall motion abnormality - echo (Presence of wall motion abnormality in at least 1 segment (2D echocardiography) [1 day]

    Presence of wall motion abnormality in at least 1 segment (2D echocardiography)

  3. Wall motion index - echo (Wall motion index (2D and 3D echocardiography) [1 day]

    Wall motion index (2D and 3D echocardiography)

  4. Global longitudinal strain (2D and 3D echocardiography) [1 day]

    Global longitudinal strain (2D and 3D echocardiography)

  5. Abnormal cardiogoniometry [1 day]

    Abnormal results of cardiogoniometry

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Coronary angiography indication present

  • informed written consent

Exclusion Criteria:
  • Previous coronary angiography

  • Known CAD (history of coronary angioplasty, stent implantation and/or bypass surgery)

  • atrial fibrillation (at time of measurement)

  • severe ventricular extrasystole (e.g. >=10% ventricular extrasystoles, bigemina)

  • pregnancy, lactation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Marcus Dörr Greifswald Germany 17475

Sponsors and Collaborators

  • University Medicine Greifswald

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marcus Doerr, Professor, University Medicine Greifswald
ClinicalTrials.gov Identifier:
NCT02404948
Other Study ID Numbers:
  • PRV-Koro-Study-001
First Posted:
Apr 1, 2015
Last Update Posted:
Jul 3, 2018
Last Verified:
Jun 1, 2018
Keywords provided by Marcus Doerr, Professor, University Medicine Greifswald
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 3, 2018